Given the pivotal role of ABCG2 in protecting cancer cells from chemotherapeutic agents by actively exporting drugs, the ability of tinodasertib to inhibit this process suggests a promising strategy to sensitize drug-resistant cells to therapy. The gene discussed is ABCG2; the disease is cancer.